Detalhe da pesquisa
1.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Lancet Oncol
; 25(3): 317-325, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342115
2.
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles.
Oncologist
; 28(3): 208-213, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527702
3.
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Future Oncol
; 19(20): 1397-1414, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318757
4.
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.
Support Care Cancer
; 32(1): 45, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114821
5.
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Support Care Cancer
; 32(1): 37, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110581
6.
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
Support Care Cancer
; 31(12): 654, 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878086
7.
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.
Oncologist
; 27(9): 722-731, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704278
8.
Molecular characterization of ESR1 variants in breast cancer.
Breast Cancer Res Treat
; 196(2): 279-289, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125660
9.
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer.
BMC Health Serv Res
; 22(1): 1403, 2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36419005
10.
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin.
Oncologist
; 26(4): 325-331, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289268
11.
Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer.
Future Oncol
; 17(8): 931-941, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207944
12.
Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer.
Future Oncol
; 17(29): 3833-3841, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254533
13.
Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer.
Future Oncol
; 17(29): 3819-3831, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34227400
14.
"Nobody Will Tell You. You've Got to Ask!": An Examination of Patient-Provider Communication Needs and Preferences among Black and White Women with Early-Stage Breast Cancer.
Health Commun
; 36(11): 1331-1342, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32336140
15.
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.
Oncologist
; 25(8): e1233-e1241, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476162
16.
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy.
Oncologist
; 25(3): e589-e597, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162813
17.
Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.
Breast Cancer Res Treat
; 182(2): 247-258, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447595
18.
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Breast Cancer Res Treat
; 184(2): 265-275, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776290
19.
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Ann Surg Oncol
; 27(3): 765-771, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907749
20.
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy.
J Natl Compr Canc Netw
; 18(6): 676-681, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502985